Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994290 · ClinicalTrials.gov registry record · NA
Evaluation of the Implementation and Effectiveness of IPP-HPV
A NA study of HPV Vaccination, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 817
- Enrollment target
- 1
- Study location
NCT02994290 is a NA study of HPV Vaccination that has completed, run by Yale University. The registered enrollment target is 817 participants, above the 483-participant average among 4 other HPV Vaccination trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02994290, a NA study of HPV Vaccination, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 817 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed pilot study is to assess the implementation of IPP-HPV immunization at Yale New Haven Hospital (YNHH) and to identify potential barriers to and facilitators of this intervention to optimize its feasibility and effectiveness. It is imperative that innovative interventions be developed to achieve comprehensive utilization of this highly effective vaccine to reduce rates of HPV infection, lower rates of cervical and other HPV associated cancers, and address cancer disparities.
Conditions Studied
Interventions
- DRUG HPV vaccine
- BEHAVIORAL Inpatient Postpartum HPV Immunization Quality Improvement Program
Study Locations (1)
Connecticut
- Yale New Haven Hospital, Women's Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 817 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994290
The ClinicalTrials.gov registry entry for NCT02994290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 817 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 483-participant average among 4 other HPV Vaccination trials with a reported enrollment target (69% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HPV Vaccination appearing as the primary indexed condition, and to 2 interventions - of which HPV vaccine is the first listed.
NCT02994290 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02994290 about?
NCT02994290 is a clinical study titled "Evaluation of the Implementation and Effectiveness of IPP-HPV". The purpose of the proposed pilot study is to assess the implementation of IPP-HPV immunization at Yale New Haven Hospital (YNHH) and to identify potential barriers to and facilitators of this intervention to optimize its feasibility and effectiveness. It is imperative that innovative interventions ...
What is the current status of trial NCT02994290?
This trial is currently completed. It is a NA study. The enrollment target is 817 participants. The study started on 2017-01. Estimated completion is 2021-10-31.
What conditions does trial NCT02994290 study?
This clinical trial studies the following conditions: HPV Vaccination.
What interventions are being tested in trial NCT02994290?
The interventions under investigation include: HPV vaccine (DRUG), Inpatient Postpartum HPV Immunization Quality Improvement Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02994290?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02994290 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
RECRUITING · NA
-
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
ACTIVE NOT RECRUITING · NA
-
PREVENT HPV -Related Cancers Trial
ACTIVE NOT RECRUITING · NA
-
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.